Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty
Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inh...
Saved in:
Published in | European journal of endocrinology Vol. 174; no. 6; pp. 785 - 790 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Bioscientifica Ltd
01.06.2016
Oxford University Press |
Subjects | |
Online Access | Get full text |
ISSN | 0804-4643 1479-683X 1479-683X |
DOI | 10.1530/EJE-15-1193 |
Cover
Abstract | Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Design Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1–14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. Methods We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using measures. Results Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (–2931±2750 pg/mL per year) and plateaued thereafter (–560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (–782±3190 vs –2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=–0.5, P<0.01), testosterone (r=–0.6, P<0.01), and inhibin B (r=–0.44, P<0.05) (n=26). Conclusion Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty. |
---|---|
AbstractList | Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels.
Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1-14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years.
We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures.
Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (-2931±2750 pg/mL per year) and plateaued thereafter (-560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (-782±3190 vs -2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=-0.5, P<0.01), testosterone (r=-0.6, P<0.01), and inhibin B (r=-0.44, P<0.05) (n=26).
Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty. Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Design Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1–14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. Methods We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures. Results Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (–2931±2750 pg/mL per year) and plateaued thereafter (–560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (–782±3190 vs –2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=–0.5, P<0.01), testosterone (r=–0.6, P<0.01), and inhibin B (r=–0.44, P<0.05) (n=26). Conclusion Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty. Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels. Design Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1–14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years. Methods We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using measures. Results Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (–2931±2750 pg/mL per year) and plateaued thereafter (–560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (–782±3190 vs –2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=–0.5, P<0.01), testosterone (r=–0.6, P<0.01), and inhibin B (r=–0.44, P<0.05) (n=26). Conclusion Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty. Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels.OBJECTIVEMakorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset of puberty. We described longitudinal changes in serum MKRN3 levels in boys before and during puberty and assessed the effect of inhibition of estrogen biosynthesis on MKRN3 levels.Longitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1-14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years.DESIGNLongitudinal serum samples from a double-blind, randomized controlled study in 30 boys (age range: 9.1-14.2years) with idiopathic short stature who received placebo (Pl; n=14) or aromatase inhibitor letrozole (Lz; 2.5mg/day; n=16) for 2years.We analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures.METHODSWe analyzed the relationships between serum MKRN3 and clinical and biochemical markers of puberty by using summary measures.Serum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (-2931±2750 pg/mL per year) and plateaued thereafter (-560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (-782±3190 vs -2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=-0.5, P<0.01), testosterone (r=-0.6, P<0.01), and inhibin B (r=-0.44, P<0.05) (n=26).RESULTSSerum MKRN3 declined by 669±713 pg/mL per year (P<0.001). This change was biphasic, as the levels decreased during Tanner genital stage G1 (-2931±2750 pg/mL per year) and plateaued thereafter (-560±1510 pg/mL per year) (P<0.05). During G1, MKRN3 levels in Lz-treated subjects decreased slower than in Pl-treated boys (-782±3190 vs -2030±821 pg/mL per year, P<0.05). The decrease in serum MKRN3 levels in G1 was associated with increases in LH (r=-0.5, P<0.01), testosterone (r=-0.6, P<0.01), and inhibin B (r=-0.44, P<0.05) (n=26).Peripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty.CONCLUSIONPeripheral MKRN3 levels in boys appear to serve as a readout of the diminishing central inhibition that controls the onset of puberty. |
Author | Varimo, Tero Hero, Matti Raivio, Taneli Miettinen, Päivi J Vaaralahti, Kirsi Dunkel, Leo |
AuthorAffiliation | William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK Hospital, University of Helsinki and Helsinki UniversityFinland Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland Research Programs Unit, Molecular Neurology, and Biomedicum Stem Cell Center, University of Helsinki, Finland |
AuthorAffiliation_xml | – name: Research Programs Unit, Molecular Neurology, and Biomedicum Stem Cell Center, University of Helsinki, Finland – name: William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK – name: Hospital, University of Helsinki and Helsinki UniversityFinland – name: Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland |
Author_xml | – sequence: 1 givenname: Tero surname: Varimo fullname: Varimo, Tero organization: Hospital, University of Helsinki and Helsinki UniversityFinland – sequence: 2 givenname: Leo surname: Dunkel fullname: Dunkel, Leo organization: William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK – sequence: 3 givenname: Kirsi surname: Vaaralahti fullname: Vaaralahti, Kirsi organization: Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland – sequence: 4 givenname: Päivi J surname: Miettinen fullname: Miettinen, Päivi J organization: Research Programs Unit, Molecular Neurology, and Biomedicum Stem Cell Center, University of Helsinki, Finland – sequence: 5 givenname: Matti surname: Hero fullname: Hero, Matti organization: Hospital, University of Helsinki and Helsinki UniversityFinland – sequence: 6 givenname: Taneli surname: Raivio fullname: Raivio, Taneli email: taneli.raivio@helsinki.fi organization: Faculty of Medicine/ Physiology, University of Helsinki, Helsinki, Finland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27025240$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU2LFDEQhoOsuLOrJ-8S8CJIa-Wju6ePMowfy8JeFLyFJF3RrJlkTNLC_PvNsLOXRfaSVFWet1K8dUHOYopIyGsGH1gv4OP2atuxvmNsEs_Iislx6oa1-HlGVrAG2clBinNyUcotAGsxvCDnfATecwkrghuf7RJ09fEX3ek_KftI8zFx7cBM9zlVbDVBA_7DUOiMNviItNVMOhRq0KWMtP5GenzwVgeaYsFKk6P7xWCuh5fkudOh4KvTfUl-fN5-33ztrm--fNt8uu6M6KfamdmuJZu54dMwz8CNYHwaJ8agH8EyI6UeJ1jPTkxCGyecQNPDgEI7BlYbcUne3fdtU_9dsFS188ViCDpiWopiTQ4cxDg09O0j9DYtObbpFAfJx4GB4I16c6IWs8NZ7bPf6XxQDwY2gN0DNqdSMjplfW1upliz9kExUMclqbakFqjjkprm_SPNQ9v_06cfjE_FeozVu2byk5o744ChOw |
CitedBy_id | crossref_primary_10_1159_000493134 crossref_primary_10_1007_s12020_017_1281_x crossref_primary_10_4274_jcrpe_galenos_2023_2022_6_6 crossref_primary_10_3389_fendo_2019_00048 crossref_primary_10_1515_jpem_2020_0331 crossref_primary_10_1172_JCI139586 crossref_primary_10_1016_j_beem_2019_101316 |
Cites_doi | 10.1038/nrendo.2015.112 10.1056/NEJMoa1302160 10.1136/bmj.300.6719.230 10.1093/humrep/deu256 10.1038/pr.2015.159 10.1111/cen.12851 10.1136/adc.45.239.13 10.1210/jc.2014-4462 10.1210/jc.2013-3126 10.1210/jc.2002-021954 10.1111/j.0954-6820.1952.tb13395.x 10.1126/science.1260419 10.1016/B978-0-12-397175-3.00032-6 10.1210/jc.2005-1392 10.1530/JME-14-0315 10.1111/cen.13027 10.1530/EJE-15-0488 |
ContentType | Journal Article |
Copyright | 2016 European Society of Endocrinology 2016 European Society of Endocrinology. Copyright BioScientifica Ltd. Jun 2016 |
Copyright_xml | – notice: 2016 European Society of Endocrinology – notice: 2016 European Society of Endocrinology. – notice: Copyright BioScientifica Ltd. Jun 2016 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
DOI | 10.1530/EJE-15-1193 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Circulating MKRN3 levels in peripubertal boys |
EISSN | 1479-683X |
EndPage | 790 |
ExternalDocumentID | 27025240 10_1530_EJE_15_1193 |
Genre | Randomized Controlled Trial Journal Article |
GroupedDBID | --- -~X .55 .GJ 0R~ 169 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 5WD AABZA AACZT AAPGJ AAPXW AAVAP AAWDT ABLYK ABOCM ABPQP ABPTD ABPTK ABSGY ABSQV ABWST ABXZS ACFRR ACGFO ACNCT ACPRK ACUTJ ADBBV ADDZX ADIPN ADQBN ADVEK AENEX AEQTP AFFNX AFGWE AFHIN AFYAG AGQXC AGUTN AI. AJEEA ALMA_UNASSIGNED_HOLDINGS ALXQX ANFBD APJGH BAWUL BCRHZ BTFSW C1A CS3 DIK DU5 E3Z EBS EJD EMOBN F9R GX1 HZ~ IL9 INIJC J5H KOP KQ8 L7B O9- OAUYM OBFPC OBOKY OCZFY OJZSN OK1 OPAEJ OVD OWPYF P2P RHF ROX SJN TBS TCN TEORI TMA TR2 VH1 W8F WOQ X7M ZA5 ZGI ZXP AARHZ AAUAY AAYXX ABDFA ABEJV ABGNP ABIME ABJNI ABMNT ABNHQ ABPIB ABQNK ABVGC ABXVV ADGKP ADMTO ADNBA ADVOB AEMQT AFXAL AHGBF AHMMS AJBYB AJNCP ATGXG CITATION H13 NU- AGORE CGR CUY CVF ECM EIF NPM 7T5 H94 7X8 |
ID | FETCH-LOGICAL-b359t-bdc841d2b296dd02b312979110570c1b44a7908df393abf3f3eb506e3af10cab3 |
ISSN | 0804-4643 1479-683X |
IngestDate | Sat Sep 27 21:12:32 EDT 2025 Fri Jul 25 05:02:40 EDT 2025 Mon Jul 21 06:06:41 EDT 2025 Wed Oct 01 04:51:13 EDT 2025 Thu Apr 24 22:57:57 EDT 2025 Sun Jan 07 07:18:52 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | 2016 European Society of Endocrinology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b359t-bdc841d2b296dd02b312979110570c1b44a7908df393abf3f3eb506e3af10cab3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | http://dx.doi.org/10.1530/EJE-15-1193 |
PMID | 27025240 |
PQID | 2042761032 |
PQPubID | 2049084 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_1790020376 proquest_journals_2042761032 pubmed_primary_27025240 crossref_citationtrail_10_1530_EJE_15_1193 crossref_primary_10_1530_EJE_15_1193 bioscientifica_primary_10_1530_EJE_15_1193 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20160600 2016-06-00 2016-Jun 20160601 |
PublicationDateYYYYMMDD | 2016-06-01 |
PublicationDate_xml | – month: 06 year: 2016 text: 20160600 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bristol |
PublicationTitle | European journal of endocrinology |
PublicationTitleAlternate | Eur J Endocrinol |
PublicationYear | 2016 |
Publisher | Bioscientifica Ltd Oxford University Press |
Publisher_xml | – name: Bioscientifica Ltd – name: Oxford University Press |
References | Kansakoski J (2016051718591929000_174.6.785.3) 2015; 78 2016051718591929000_174.6.785.6 2016051718591929000_174.6.785.7 2016051718591929000_174.6.785.8 2016051718591929000_174.6.785.1 2016051718591929000_174.6.785.2 2016051718591929000_174.6.785.4 2016051718591929000_174.6.785.16 2016051718591929000_174.6.785.14 2016051718591929000_174.6.785.15 2016051718591929000_174.6.785.9 2016051718591929000_174.6.785.13 2016051718591929000_174.6.785.11 Boehm (2016051718591929000_174.6.785.17) 2015; 11 Simon (2016051718591929000_174.6.785.12) 2015; 174 Hagen (2016051718591929000_174.6.785.5) 2015; 100 Hansen (2016051718591929000_174.6.785.10) 1952; 266 |
References_xml | – volume: 11 start-page: 547 year: 2015 ident: 2016051718591929000_174.6.785.17 article-title: Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism – pathogenesis, diagnosis and treatment publication-title: Nature Reviews Endocrinology doi: 10.1038/nrendo.2015.112 – ident: 2016051718591929000_174.6.785.1 doi: 10.1056/NEJMoa1302160 – ident: 2016051718591929000_174.6.785.11 doi: 10.1136/bmj.300.6719.230 – ident: 2016051718591929000_174.6.785.14 doi: 10.1093/humrep/deu256 – volume: 78 start-page: 709 year: 2015 ident: 2016051718591929000_174.6.785.3 article-title: A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty publication-title: Pediatric Research doi: 10.1038/pr.2015.159 – ident: 2016051718591929000_174.6.785.6 doi: 10.1111/cen.12851 – ident: 2016051718591929000_174.6.785.9 doi: 10.1136/adc.45.239.13 – volume: 100 start-page: 1920 year: 2015 ident: 2016051718591929000_174.6.785.5 article-title: Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls publication-title: Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jc.2014-4462 – ident: 2016051718591929000_174.6.785.15 doi: 10.1210/jc.2013-3126 – ident: 2016051718591929000_174.6.785.16 doi: 10.1210/jc.2002-021954 – volume: 266 start-page: 457 year: 1952 ident: 2016051718591929000_174.6.785.10 article-title: Clinical measurements of the testes in boys and men publication-title: Acta Medica Scandinavica Supplementum doi: 10.1111/j.0954-6820.1952.tb13395.x – ident: 2016051718591929000_174.6.785.4 doi: 10.1126/science.1260419 – ident: 2016051718591929000_174.6.785.13 doi: 10.1016/B978-0-12-397175-3.00032-6 – ident: 2016051718591929000_174.6.785.8 doi: 10.1210/jc.2005-1392 – ident: 2016051718591929000_174.6.785.2 doi: 10.1530/JME-14-0315 – ident: 2016051718591929000_174.6.785.7 doi: 10.1111/cen.13027 – volume: 174 start-page: 1 year: 2015 ident: 2016051718591929000_174.6.785.12 article-title: Mutations in the maternally imprinted gene MKRN3 are common in familial central precocious puberty publication-title: European Journal of Endocrinology doi: 10.1530/EJE-15-0488 |
SSID | ssj0016430 |
Score | 2.2323222 |
Snippet | Objective Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic–pituitary–gonadal axis. In girls, peripheral levels of MKRN3 decline prior to... Makorin ring finger protein 3 (MKRN3) gene restrains the hypothalamic-pituitary-gonadal axis. In girls, peripheral levels of MKRN3 decline prior to the onset... |
SourceID | proquest pubmed crossref bioscientifica |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 785 |
SubjectTerms | Adolescent Aromatase Aromatase Inhibitors - therapeutic use Biochemical markers Child Clinical Study Clinical trials Double-Blind Method Growth Disorders - blood Growth Disorders - drug therapy Humans Hypothalamus Inhibin Letrozole Male Nitriles - therapeutic use Pituitary Puberty Puberty - blood Ribonucleoproteins - blood Testosterone Treatment Outcome Triazoles - therapeutic use |
Title | Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty |
URI | http://dx.doi.org/10.1530/EJE-15-1193 https://www.ncbi.nlm.nih.gov/pubmed/27025240 https://www.proquest.com/docview/2042761032 https://www.proquest.com/docview/1790020376 |
Volume | 174 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1479-683X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0016430 issn: 0804-4643 databaseCode: KQ8 dateStart: 19480601 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1479-683X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0016430 issn: 0804-4643 databaseCode: KQ8 dateStart: 19970701 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1479-683X dateEnd: 20241002 omitProxy: true ssIdentifier: ssj0016430 issn: 0804-4643 databaseCode: GX1 dateStart: 19980101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbKkBBIINj4URjISNMeqDKSOHaSx2nqNI1ugNSivkV24ohqazL6A2m88o9zZ7tpCx0avESR68ZRvi-Xs_3dHSF7CU_iRPnS40UZelGcMC_VpfQCJksGd85jhQv6Z-fiZBCdDvmw1fq5olqaz9RB_mNjXMn_oAptgCtGyf4Dss1FoQHOAV84AsJwvBXGR6NJbspvwXR_LC9QS9cxerrSphc0SRigjXUuURs07RQ6N24ltKn6etpRGnxWbZzPJkQS5dVGHgBIYeLdG9funR-rq6IG07O-Pv8FpuBjswrb15N6xVu-sKqAnq6XXSUGc351ugJcRWlYMNIoy7aW8ZPZ049G30duK8utVQRiqaly5jWKU08kpgIwfH02tC1ssi3d48i3amFjW-HnD8vPGUolu6ddL-BeENiyi-v5tc8_ZseDXi_rd4f9_atvHpYewy16V4flDrkbxkJgGYwPn5dbUeCymajaxW26IE8Y7_3KaA_IQzWy6UeNxus3P-eGyYtxYvqPySM3-6CHlkpPSEtX22TnsJKzenxN96nRAxsgt8m9Mye72CF6hWjUEY0i0aglGnVEo4xaolFHNAptSDRqiUaBaHRBNGqIRuuSOqI9JYPjbv_oxHP1OTzFeDrzVJEnUVCEKkxFUfihYuA8xvD1hDmAnwcqimSc-klRspRJVTJ4-RX3hQYzEPi5VOwZ2arqSr8gVKg0h4-zkiUmkpZBooJcc8m1ZnlSiLJN3q0_3uzKJmPJcBILWGSABZxkiAV0Xjz6LHeZ7rHgyuXmzntN579ec3eBYeZesWkWYqEagSkp2-Rt8zPYZ9x0k5Wu59MMM-Dhbn8s2uS5xb4ZB2NBObjUL2_x71fk_vKN2iVbs8lcvwZ_eKbeGL7-AkWvuXI |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Circulating+makorin+ring+finger+protein+3+levels+decline+in+boys+before+the+clinical+onset+of+puberty&rft.jtitle=European+journal+of+endocrinology&rft.au=Varimo%2C+Tero&rft.au=Dunkel%2C+Leo&rft.au=Vaaralahti%2C+Kirsi&rft.au=Miettinen%2C+P%C3%A4ivi+J&rft.date=2016-06-01&rft.issn=1479-683X&rft.eissn=1479-683X&rft.volume=174&rft.issue=6&rft.spage=785&rft_id=info:doi/10.1530%2FEJE-15-1193&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon |